USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Microneedle Technologies Creating Novel Opportunities in Transdermal Drug Delivery Industry
29-Dec-2017
North America
Technology Research
D807-01-00-00-00
HC02954-NA-TR_21382
With the healthcare industry moving toward patient convenience and comfort, pharmaceutical and medical device companies are continuously researching for the most effective, side effect free, convenient route of drug delivery. Transdermal drug delivery is a painless method of delivering drug formulation. Transdermal route of drug administration has several inherent limitations which can be overcome by technology innovations such as skin ablation (laser, radio frequency), electrical (iontophoresis and electroportation), mechanical (microneedle) methods. This research report focuses different technology innovations, key innovators in this space, industry trends, and impact across different therapeutic areas.
1.1 Scope of the Research
1.2 Research Methodology
1.2 Research Methodology (continued)
1.3 Key Findings
2.1 Transdermal Drug Delivery: A Promising Method of Drug Delivery
2.2 Evolution of Transdermal Drug Delivery Technologies
2.3 Technology Innovations Addressing Conventional Transdermal Delivery Challenges
2.4 Active and Passive Transdermal Drug Delivery Technologies
3.1 Skin Ablation for Transdermal Drug Delivery
3.1.1 Company Skin Ablation Innovations for Transdermal Drug Delivery
3.1.2 University Skin Ablation Innovations for Transdermal Drug Delivery
3.2 Transdermal Drug Delivery Assisted by Electrical Technologies
3.2.1 Iontophoretic Transdermal System for Managing Pain and Migraine
3.3 Ultrasound for Transdermal Drug Delivery
3.4 Convenient, Easy-to-Use Microneedle Patch with Efficacy of Conventional Needle Injection
3.4.1 Different Delivery Strategies Using Microneedles
3.4.2 Solid and Liquid Dose Microneedle Drug Delivery Device
3.4.3 Dissolving Microneedle Patch Technology for Flu Vaccination
3.4.4 Customizable, Metal-based Hollow Microneedle Technology
3.4.5 Proprietary Microneedle Fabrication Technology
3.4.6 Dissolvable Microneedle Patch to Deliver Chemotherapeutic Agent for Treating Skin Cancer
3.4.7 Dissolving Microneedle Patches for Cosmetic Applications
3.4.8 Recent Microneedle Patents for Antiaging
3.4.9 Recent Microneedle Innovations from Patent Analysis
3.4.10 Recent Microneedle Patents from Universities
4.1 Transdermal Drug Delivery Solutions Impact Pain, Neurological and Hormonal Indications
4.1.1 Phase 1 Clinical Trial Assessment Shows Active Research Across Therapeutic Areas
4.1.2 Phase 2 Clinical Trial Assessment Shows Active Research Across Transdermal Cancer and Hormonal Therapy
4.1.3 Phase 3 Clinical Trial Assessment Shows Active Research for Transdermal Neurological Therapy
4.1.4 Key Transdermal Therapy Clinical Trials Across Phases
4.2.1 Active Industry Partnerships and Alliances in Transdermal Drug Delivery Industry
4.2.2 Microneedle Technology Licensed from Universities
4.2.3 Transdermal Technologies Licensed for by Key Companies
4.3.1 Funding Assessment Indicates Market Interest Toward Microneedle Technology
4.3.2 National Institute of Allergy and Infectious Diseases is the Top Funding Federal Agency for Transdermal Drug Delivery
4.3.3 Key Federal Funded Research Projects for Transdermal Drug Delivery
5.1 Transdermal Drug Delivery Industry Innovation Ecosystem: Key Innovators
5.2.1 Growth Opportunities: Advanced Microneedles
5.2.2 Growth Opportunities: Transdermal Gene Delivery
5.2.3 Growth Opportunities: Smart Transdermal Patches
5.3.1 Technology Roadmap of the Transdermal Drug Delivery Industry
5.3.2 Technology Roadmap Overview
5.3.3 Technology Roadmap of the Transdermal Drug Delivery Industry (Legend)
5.3.4 Technology Roadmap of the Transdermal Drug Delivery Industry – Explained
5.4 Technology Convergence for Advanced Transdermal Drug Delivery
5.5 Emerging Cross Cluster Technologies are Set to Revolutionize the Future Transdermal Drug Delivery Industry
5.6 Strategic Recommendations for Transdermal Drug Delivery Industry Growth
6.1 Key Industry Contacts
6.1 Key Industry Contacts (continued)
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Technology Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Debarati Sengupta |
| Industries | Healthcare |
| WIP Number | D807-01-00-00-00 |
| Is Prebook | No |
Innovations in Transdermal Drug Delivery
$4,950.00
Special Price $3,712.50 save 25 %